For four straight years recently, despite annual budget cutbacks, the National Institutes of Health managed to record steady gains in a critical measure: the share of its main grant awards won by new scientists. Through a combination of new award programs and tweaks to existing policies, the agency fought to protect the young scientists it considered crucial to the long-term success of the nation’s biomedical enterprise.